The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

被引：0
|
作者：
SR Young
Robert T Pilarski
Talia Donenberg
Charles Shapiro
Lyn S Hammond
Judith Miller
Karen A Brooks
Stephanie Cohen
Beverly Tenenholz
Damini DeSai
Inuk Zandvakili
Robert Royer
Song Li
Steven A Narod
机构：
[1] University of South Carolina School of Medicine,Department of Obstetrics and Gynecology
[2] Ohio State University,Department of Internal Medicine, Clinical Cancer Genetics Program
[3] Department of Obstetrics & GynecologyUniversity of Miami/Jackson Health System,Department of Internal Medicine, Division of Hematology and Oncology
[4] Ohio State University,Division of Genetics
[5] Medical University of South Carolina,Carle Clinic Medical Genetics
[6] University of Illinois College of Medicine,Medical Genetics
[7] St. Vincent Hospital,Women's College Research Institute, Department of Public Health
[8] Geisinger Medical Center,undefined
[9] Joe Arrington Cancer Center,undefined
[10] The University of Toronto,undefined
来源：
BMC Cancer | / 9卷
关键词：
Breast Cancer; Ovarian Cancer; Male Breast Cancer; Basal Phenotype; Significant Family History;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    Young, S. R.
    Pilarski, Robert T.
    Donenberg, Talia
    Shapiro, Charles
    Hammond, Lyn S.
    Miller, Judith
    Brooks, Karen A.
    Cohen, Stephanie
    Tenenholz, Beverly
    DeSai, Damini
    Zandvakili, Inuk
    Royer, Robert
    Li, Song
    Narod, Steven A.
    BMC CANCER, 2009, 9
  • [2] Prevalence of BRCA1 mutations among 284 women with triple-negative breast cancer
    Fostira, F.
    Tsitlaidou, M.
    Gogas, H.
    Pertesi, M.
    Yannoukakos, D.
    Bournakis, E.
    Karavassilis, V.
    Skarlos, P.
    Konstantopoulou, I.
    Fountzilas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
    Villarreal-Garza, C.
    Weitzel, J. N.
    Llacuachaqui, M.
    Sifuentes, E.
    Magallanes-Hoyos, M. C.
    Gallardo, L.
    Alvarez-Gomez, R. M.
    Herzog, J.
    Castillo, D.
    Royer, R.
    Akbari, Mohammad
    Lara-Medina, F.
    Herrera, L. A.
    Mohar, A.
    Narod, S. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (02) : 389 - 394
  • [4] The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
    C. Villarreal-Garza
    J. N. Weitzel
    M. Llacuachaqui
    E. Sifuentes
    M. C. Magallanes-Hoyos
    L. Gallardo
    R. M. Alvarez-Gómez
    J. Herzog
    D. Castillo
    R. Royer
    Mohammad Akbari
    F. Lara-Medina
    L. A. Herrera
    A. Mohar
    S. A. Narod
    Breast Cancer Research and Treatment, 2015, 150 : 389 - 394
  • [5] Prevalence of BRCA1 mutations in women with triple-negative breast cancer: A systematic review
    Tun, N. M.
    Villani, G. M.
    Ong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [6] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Wong-Brown, Michelle W.
    Meldrum, Cliff J.
    Carpenter, Jane E.
    Clarke, Christine L.
    Narod, Steven A.
    Jakubowska, Anna
    Rudnicka, Helena
    Lubinski, Jan
    Scott, Rodney J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) : 71 - 80
  • [7] Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
    Michelle W. Wong-Brown
    Cliff J. Meldrum
    Jane E. Carpenter
    Christine L. Clarke
    Steven A. Narod
    Anna Jakubowska
    Helena Rudnicka
    Jan Lubinski
    Rodney J. Scott
    Breast Cancer Research and Treatment, 2015, 150 : 71 - 80
  • [8] Prevalence of BRCA1 and BRCA2 mutations in Jewish women with triple negative breast cancer
    Comen, E. A.
    Davids, M.
    Kirchhoff, T.
    Balistreri, L.
    Hansen, J.
    Kosarin, K.
    Offit, K.
    Robson, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer
    Wang, C.
    Zhang, J.
    Wang, Y.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Xie, Y.
    ANNALS OF ONCOLOGY, 2015, 26 (03) : 523 - 528
  • [10] Prevalence of BRCA1 mutations in triple negative breast cancer (BC).
    Kandel, M. J.
    Stadler, Z.
    Masciari, S.
    Collins, L.
    Schnitt, S.
    Harris, L.
    Miron, A.
    Richardson, A.
    Garber, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 5S - 5S
12345